Global Nanomedicine 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR072409045

Publication Date:

July 15, 2024

Pages:

110

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Nanomedicine market size was valued at USD 160 million in 2023 and is forecast to a readjusted size of USD 242.6 million by 2030 with a CAGR of 6.1% during review period.
Nanomedicine is the medical application of nanotechnology.Nanomedicine ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines.
Nanomedicine refers to the application of nanotechnology in the field of medicine. It involves the use of nanoparticles, nanomaterials, and nanodevices to deliver drugs, diagnose diseases, and monitor the health of patients at the molecular level.

Nanoparticles and nanomaterials can be engineered to have specific properties, such as size, shape, and surface chemistry, which allow for targeted and controlled delivery of drugs to specific cells or tissues in the body. This targeted drug delivery system increases the efficiency and effectiveness of treatments while minimizing side effects.

In addition to drug delivery, nanomedicine also includes the development of nanosensors and nanodevices for diagnostic purposes. These tiny devices can detect molecular markers of diseases, such as proteins or genetic material, at an early stage, enabling early intervention and personalized medicine. Nanosensors can also be used to monitor the health of patients in real-time, providing continuous data on various health parameters.

Nanomedicine has the potential to revolutionize healthcare by providing more precise and personalized treatments. It has the potential to improve drug efficacy, reduce drug toxicity, and enhance patient outcomes. However, there are still challenges that need to be addressed, such as the safety and toxicity of nanoparticles, as well as regulatory approval processes for nano-based medical products.
This report includes an overview of the development of the Nanomedicine industry chain, the market status of oncology (Quantum dots, Nanoparticles), Infectious diseases (Quantum dots, Nanoparticles), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Nanomedicine.
Regionally, the report analyzes the Nanomedicine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Nanomedicine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Nanomedicine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Nanomedicine industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Quantum dots, Nanoparticles).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Nanomedicine market.
Regional Analysis: The report involves examining the Nanomedicine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Nanomedicine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Nanomedicine:
Company Analysis: Report covers individual Nanomedicine players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Nanomedicine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (oncology, Infectious diseases).
Technology Analysis: Report covers specific technologies relevant to Nanomedicine. It assesses the current state, advancements, and potential future developments in Nanomedicine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Nanomedicine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Nanomedicine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Quantum dots
Nanoparticles
Nanoshells
Nanotubes
Nanodevices
麻豆原创 segment by Application
oncology
Infectious diseases
Cardiology
Orthopedics
Others
麻豆原创 segment by players, this report covers
Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nanomedicine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nanomedicine, with revenue, gross margin and global market share of Nanomedicine from 2019 to 2024.
Chapter 3, the Nanomedicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Nanomedicine market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nanomedicine.
Chapter 13, to describe Nanomedicine research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Nanomedicine
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Nanomedicine by Type
1.3.1 Overview: Global Nanomedicine 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Nanomedicine Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Quantum dots
1.3.4 Nanoparticles
1.3.5 Nanoshells
1.3.6 Nanotubes
1.3.7 Nanodevices
1.4 Global Nanomedicine 麻豆原创 by Application
1.4.1 Overview: Global Nanomedicine 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 oncology
1.4.3 Infectious diseases
1.4.4 Cardiology
1.4.5 Orthopedics
1.4.6 Others
1.5 Global Nanomedicine 麻豆原创 Size & Forecast
1.6 Global Nanomedicine 麻豆原创 Size and Forecast by Region
1.6.1 Global Nanomedicine 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Nanomedicine 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Nanomedicine 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Nanomedicine 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Nanomedicine 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Nanomedicine 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Nanomedicine 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Combimatrix
2.1.1 Combimatrix Details
2.1.2 Combimatrix Major Business
2.1.3 Combimatrix Nanomedicine Product and Solutions
2.1.4 Combimatrix Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Combimatrix Recent Developments and Future Plans
2.2 Ablynx
2.2.1 Ablynx Details
2.2.2 Ablynx Major Business
2.2.3 Ablynx Nanomedicine Product and Solutions
2.2.4 Ablynx Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Ablynx Recent Developments and Future Plans
2.3 Abraxis Bioscience
2.3.1 Abraxis Bioscience Details
2.3.2 Abraxis Bioscience Major Business
2.3.3 Abraxis Bioscience Nanomedicine Product and Solutions
2.3.4 Abraxis Bioscience Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Abraxis Bioscience Recent Developments and Future Plans
2.4 Celgene
2.4.1 Celgene Details
2.4.2 Celgene Major Business
2.4.3 Celgene Nanomedicine Product and Solutions
2.4.4 Celgene Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Celgene Recent Developments and Future Plans
2.5 Mallinckrodt
2.5.1 Mallinckrodt Details
2.5.2 Mallinckrodt Major Business
2.5.3 Mallinckrodt Nanomedicine Product and Solutions
2.5.4 Mallinckrodt Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Mallinckrodt Recent Developments and Future Plans
2.6 Arrowhead Research
2.6.1 Arrowhead Research Details
2.6.2 Arrowhead Research Major Business
2.6.3 Arrowhead Research Nanomedicine Product and Solutions
2.6.4 Arrowhead Research Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Arrowhead Research Recent Developments and Future Plans
2.7 GE Healthcare
2.7.1 GE Healthcare Details
2.7.2 GE Healthcare Major Business
2.7.3 GE Healthcare Nanomedicine Product and Solutions
2.7.4 GE Healthcare Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 GE Healthcare Recent Developments and Future Plans
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business
2.8.3 Merck Nanomedicine Product and Solutions
2.8.4 Merck Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Merck Recent Developments and Future Plans
2.9 Pfizer
2.9.1 Pfizer Details
2.9.2 Pfizer Major Business
2.9.3 Pfizer Nanomedicine Product and Solutions
2.9.4 Pfizer Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Pfizer Recent Developments and Future Plans
2.10 Nanosphere
2.10.1 Nanosphere Details
2.10.2 Nanosphere Major Business
2.10.3 Nanosphere Nanomedicine Product and Solutions
2.10.4 Nanosphere Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Nanosphere Recent Developments and Future Plans
2.11 Epeius Biotechnologies
2.11.1 Epeius Biotechnologies Details
2.11.2 Epeius Biotechnologies Major Business
2.11.3 Epeius Biotechnologies Nanomedicine Product and Solutions
2.11.4 Epeius Biotechnologies Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.11.5 Epeius Biotechnologies Recent Developments and Future Plans
2.12 Cytimmune Sciences
2.12.1 Cytimmune Sciences Details
2.12.2 Cytimmune Sciences Major Business
2.12.3 Cytimmune Sciences Nanomedicine Product and Solutions
2.12.4 Cytimmune Sciences Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.12.5 Cytimmune Sciences Recent Developments and Future Plans
2.13 Nanospectra Biosciences
2.13.1 Nanospectra Biosciences Details
2.13.2 Nanospectra Biosciences Major Business
2.13.3 Nanospectra Biosciences Nanomedicine Product and Solutions
2.13.4 Nanospectra Biosciences Nanomedicine Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.13.5 Nanospectra Biosciences Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Nanomedicine Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Nanomedicine by Company Revenue
3.2.2 Top 3 Nanomedicine Players 麻豆原创 Share in 2023
3.2.3 Top 6 Nanomedicine Players 麻豆原创 Share in 2023
3.3 Nanomedicine 麻豆原创: Overall Company Footprint Analysis
3.3.1 Nanomedicine 麻豆原创: Region Footprint
3.3.2 Nanomedicine 麻豆原创: Company Product Type Footprint
3.3.3 Nanomedicine 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Nanomedicine Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Nanomedicine 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Nanomedicine Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Nanomedicine 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Nanomedicine Consumption Value by Type (2019-2030)
6.2 North America Nanomedicine Consumption Value by Application (2019-2030)
6.3 North America Nanomedicine 麻豆原创 Size by Country
6.3.1 North America Nanomedicine Consumption Value by Country (2019-2030)
6.3.2 United States Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Nanomedicine Consumption Value by Type (2019-2030)
7.2 Europe Nanomedicine Consumption Value by Application (2019-2030)
7.3 Europe Nanomedicine 麻豆原创 Size by Country
7.3.1 Europe Nanomedicine Consumption Value by Country (2019-2030)
7.3.2 Germany Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Nanomedicine Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Nanomedicine Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Nanomedicine 麻豆原创 Size by Region
8.3.1 Asia-Pacific Nanomedicine Consumption Value by Region (2019-2030)
8.3.2 China Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Nanomedicine Consumption Value by Type (2019-2030)
9.2 South America Nanomedicine Consumption Value by Application (2019-2030)
9.3 South America Nanomedicine 麻豆原创 Size by Country
9.3.1 South America Nanomedicine Consumption Value by Country (2019-2030)
9.3.2 Brazil Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Nanomedicine Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Nanomedicine Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Nanomedicine 麻豆原创 Size by Country
10.3.1 Middle East & Africa Nanomedicine Consumption Value by Country (2019-2030)
10.3.2 Turkey Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Nanomedicine 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Nanomedicine 麻豆原创 Drivers
11.2 Nanomedicine 麻豆原创 Restraints
11.3 Nanomedicine Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Nanomedicine Industry Chain
12.2 Nanomedicine Upstream Analysis
12.3 Nanomedicine Midstream Analysis
12.4 Nanomedicine Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Combimatrix
Ablynx
Abraxis Bioscience
Celgene
Mallinckrodt
Arrowhead Research
GE Healthcare
Merck
Pfizer
Nanosphere
Epeius Biotechnologies
Cytimmune Sciences
Nanospectra Biosciences

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.